Earnings ·
Takeda reports H1 net profit of JPY 305.7 billion, up 172% on FX and lower impairments
TKPHFTakeda Pharmaceutical Co Ltd
Takeda Pharmaceutical reported a six-month net profit attributable to owners of the Company of JPY 305.6 billion (USD approx. $2.04 billion), a 171.8% increase from the prior year period, driven by foreign exchange tailwinds and significantly lower amortization and impairment losses. Revenue rose 8.4% to JPY 2,407.0 billion, with operating profit surging 60.4% to JPY 406.7 billion. The company also redeemed USD 1,500 million of senior notes during the period. Takeda is a global pharmaceutical company focused on gastroenterology, oncology, neuroscience, and rare diseases.